NCT01712659 2023-01-10Ruxolitinib for Adult T-Cell LeukemiaNational Institutes of Health Clinical Center (CC)Phase 1/2 Terminated19 enrolled 17 charts
NCT00117845 2019-11-19Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell LeukemiaNational Institutes of Health Clinical Center (CC)Phase 2 Terminated17 enrolled 9 charts